Compare Stocks: EKTAY, SARTF, SSMXY, and TFX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EKTAY Elekta	$5.09 +0.8%	$5.24	$4.35 ▼ $6.93	$1.86B	1.01	5,215 shs	6,689 shs
SARTF Sartorius	$212.80	$212.22	$181.58 ▼ $227.00	$7.28B	0.98	255 shs	N/A
SSMXY Sysmex	$10.06 +0.9%	$9.25	$8.01 ▼ $16.83	$6.28B	1.05	63,820 shs	21,669 shs
TFX Teleflex	$139.86 +2.3%	$131.11	$100.18 ▼ $144.19	$6.05B	0.81	428,353 shs	1.01 million shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EKTAY Elekta	+0.81%	+3.18%	-3.69%	-14.74%	+6.53%
SARTF Sartorius	0.00%	0.00%	0.00%	+0.21%	+15.49%
SSMXY Sysmex	+0.94%	+3.22%	+6.50%	+19.52%	-39.08%
TFX Teleflex	+2.30%	+6.68%	+4.30%	+15.87%	+20.70%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EKTAY Elekta	$5.09 +0.8%	$5.24	$4.35 ▼ $6.93	$1.86B	1.01	5,215 shs	6,689 shs
SARTF Sartorius	$212.80	$212.22	$181.58 ▼ $227.00	$7.28B	0.98	255 shs	N/A
SSMXY Sysmex	$10.06 +0.9%	$9.25	$8.01 ▼ $16.83	$6.28B	1.05	63,820 shs	21,669 shs
TFX Teleflex	$139.86 +2.3%	$131.11	$100.18 ▼ $144.19	$6.05B	0.81	428,353 shs	1.01 million shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EKTAY Elekta	+0.81%	+3.18%	-3.69%	-14.74%	+6.53%
SARTF Sartorius	0.00%	0.00%	0.00%	+0.21%	+15.49%
SSMXY Sysmex	+0.94%	+3.22%	+6.50%	+19.52%	-39.08%
TFX Teleflex	+2.30%	+6.68%	+4.30%	+15.87%	+20.70%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EKTAY Elekta	1.50	Reduce	N/A	N/A
SARTF Sartorius	4.00	Strong Buy	N/A	N/A
SSMXY Sysmex	2.00	Hold	N/A	N/A
TFX Teleflex	2.42	Hold	$148.90	6.47% Upside

Current Analyst Ratings Breakdown

Latest EKTAY, SARTF, SSMXY, and TFX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	TFX Teleflex	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$147.00 ➝ $159.00
7/28/2026	TFX Teleflex	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$145.00
7/28/2026	EKTAY Elekta	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/28/2026	TFX Teleflex	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$145.00
7/15/2026	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$140.00 ➝ $145.00
7/14/2026	SSMXY Sysmex	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/8/2026	TFX Teleflex	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$159.00
7/8/2026	TFX Teleflex	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
6/24/2026	TFX Teleflex	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
6/8/2026	TFX Teleflex	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$140.00 ➝ $160.00
6/2/2026	EKTAY Elekta	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell

(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EKTAY Elekta	$1.78B	1.05	$0.63 per share	8.03	$2.07 per share	2.46
SARTF Sartorius	$3.66B	1.99	N/A	N/A	N/A	∞
SSMXY Sysmex	$3.32B	1.91	$0.87 per share	11.58	$5.30 per share	1.90
TFX Teleflex	$1.99B	3.11	$11.45 per share	12.22	$70.71 per share	1.98

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EKTAY Elekta	-$55.38M	-$0.16	N/A	10.83	N/A	-3.32%	11.11%	3.25%	8/27/2026 (Estimated)
SARTF Sartorius	$90.90M	$2.15	98.98	N/A	N/A	3.82%	8.19%	3.15%	10/22/2026 (Estimated)
SSMXY Sysmex	$234.01M	$0.38	26.48	19.73	N/A	7.13%	7.23%	5.20%	8/5/2026 (Estimated)
TFX Teleflex	-$905.64M	-$22.80	N/A	13.26	1.02	-35.88%	13.29%	6.55%	8/6/2026 (Estimated)

Latest EKTAY, SARTF, SSMXY, and TFX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	TFX Teleflex	$1.28	N/A	N/A	N/A	$559.59 million	N/A
8/5/2026	N/A	SSMXY Sysmex	$0.07	N/A	N/A	N/A	$741.40 million	N/A
5/28/2026	Q4 2026	EKTAY Elekta	N/A	$0.06	N/A	-$0.25	N/A	$521.00 million
5/14/2026	Q4 2026	SSMXY Sysmex	$0.0374	$0.02	-$0.0174	$0.02	$862.45 million	$877.92 million
5/7/2026	Q1 2026	TFX Teleflex	$1.21	$1.39	+$0.18	-$0.18	$536.91 million	$548.30 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
EKTAY Elekta	$0.13	2.55%	N/A	N/A	N/A
SARTF Sartorius	N/A	N/A	N/A	N/A	N/A
SSMXY Sysmex	$0.14	1.39%	N/A	36.84%	N/A
TFX Teleflex	$1.36	0.97%	N/A	N/A	N/A

Latest EKTAY, SARTF, SSMXY, and TFX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/15/2026	TFX Teleflex	quarterly	$0.34	1.03%	5/22/2026	5/25/2026	6/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EKTAY Elekta	0.47	0.87	0.68
SARTF Sartorius	0.89	0.95	0.49
SSMXY Sysmex	0.12	3.26	2.46
TFX Teleflex	0.82	2.55	2.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EKTAY Elekta	N/A
SARTF Sartorius	N/A
SSMXY Sysmex	N/A
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
EKTAY Elekta	41.28%
SARTF Sartorius	N/A
SSMXY Sysmex	N/A
TFX Teleflex	0.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EKTAY Elekta	4,556	368.59 million	216.44 million	Not Optionable
SARTF Sartorius	13,528	34.23 million	N/A	Not Optionable
SSMXY Sysmex	11,457	629.48 million	N/A	Not Optionable
TFX Teleflex	15,500	44.27 million	43.96 million	Optionable

EKTAY, SARTF, SSMXY, and TFX Headlines

Recent News About These Companies

Teleflex Completes OEM Business Sale to Montagu, Kohlberg

August 3 at 6:51 PM | tipranks.com

Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion

August 3 at 6:01 PM | finance.yahoo.com

Why Is Teleflex (NYSE:TFX) in Focus After FDA Approval?

August 3 at 6:01 PM | kalkinemedia.comK

Teleflex (NYSE:TFX) Reaches New 52-Week High - Here's Why

August 3 at 10:59 AM | marketbeat.com

Teleflex Incorporated $TFX Shares Sold by The Manufacturers Life Insurance Company

August 2 at 5:20 AM | marketbeat.com

Teleflex Incorporated $TFX Shares Sold by Sei Investments Co.

August 2 at 4:55 AM | marketbeat.com

Teleflex Incorporated $TFX Shares Sold by Lazard Asset Management LLC

August 1 at 5:44 AM | marketbeat.com

Teleflex (NYSE:TFX) Downgraded by Wall Street Zen to Sell

August 1 at 1:23 AM | marketbeat.com

Teleflex Inc. stock outperforms competitors despite losses on the day

July 31, 2026 | marketwatch.com

Teleflex (NYSE:TFX) Earns Neutral Rating from Analysts at UBS Group

July 31, 2026 | americanbankingnews.com

Janus Henderson Group PLC Raises Position in Teleflex Incorporated $TFX

July 30, 2026 | marketbeat.com

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

July 29, 2026 | finance.yahoo.com

Teleflex (NYSE:TFX) Raised to "Hold" at UBS Group

July 29, 2026 | marketbeat.com

Irenic Capital Management LP Takes $104.06 Million Position in Teleflex Incorporated $TFX

July 29, 2026 | marketbeat.com

Dimensional Fund Advisors LP Has $119.26 Million Stock Holdings in Teleflex Incorporated $TFX

July 29, 2026 | marketbeat.com

Teleflex Incorporated $TFX Stake Lessened by ADAR1 Capital Management LLC

July 29, 2026 | marketbeat.com

California Public Employees Retirement System Has $6.79 Million Stock Holdings in Teleflex Incorporated $TFX

July 27, 2026 | marketbeat.com

Arrowstreet Capital Limited Partnership Lowers Stock Position in Teleflex Incorporated $TFX

July 27, 2026 | marketbeat.com

Teleflex (NYSE:TFX) versus ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Contrast

July 26, 2026 | americanbankingnews.com

GC Wealth Management RIA LLC Invests $1.49 Million in Teleflex Incorporated $TFX

July 25, 2026 | marketbeat.com

Systematic Financial Management LP Takes Position in Teleflex Incorporated $TFX

July 25, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

EKTAY, SARTF, SSMXY, and TFX Company Descriptions

Elekta OTCMKTS:EKTAY

$5.09 +0.04 (+0.81%)

As of 08/3/2026 02:01 PM Eastern

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Sartorius OTCMKTS:SARTF

$212.80 0.00 (0.00%)

As of 07/31/2026

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Sysmex OTCMKTS:SSMXY

$10.06 +0.09 (+0.94%)

As of 08/3/2026 03:50 PM Eastern

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Teleflex NYSE:TFX

$139.86 +3.15 (+2.30%)

Closing price 08/3/2026 03:59 PM Eastern

Extended Trading

$139.82 -0.04 (-0.03%)

As of 08/3/2026 07:53 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EKTAY, SARTF, SSMXY, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EKTAY, SARTF, SSMXY, and TFX Earnings

Compare Dividends

Latest EKTAY, SARTF, SSMXY, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EKTAY, SARTF, SSMXY, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EKTAY, SARTF, SSMXY, and TFX Company Descriptions

Elekta OTCMKTS:EKTAY

Sartorius OTCMKTS:SARTF

Sysmex OTCMKTS:SSMXY

Teleflex NYSE:TFX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EKTAY, SARTF, SSMXY, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EKTAY, SARTF, SSMXY, and TFX Earnings

Compare Dividends

Latest EKTAY, SARTF, SSMXY, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EKTAY, SARTF, SSMXY, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

EKTAY, SARTF, SSMXY, and TFX Company Descriptions

Elekta OTCMKTS:EKTAY

Sartorius OTCMKTS:SARTF

Sysmex OTCMKTS:SSMXY

Teleflex NYSE:TFX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools